Jacobs Levy Equity Management’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,266
Closed -$371K 1022
2025
Q4
$371K Sell
60,266
-23,437
-28% -$174K ﹤0.01% 836
2025
Q3
$814K Sell
83,703
-4,752
-5% -$59.5K ﹤0.01% 754
2025
Q2
$1.16M Buy
+88,455
New +$1.14M ﹤0.01% 730
2021
Q4
Sell
-91,307
Closed -$618K 1030
2021
Q3
$618K Buy
91,307
+30,729
+51% +$226K ﹤0.01% 836
2021
Q2
$445K Sell
60,578
-48,761
-45% -$398K ﹤0.01% 884
2021
Q1
$1.02M Sell
109,339
-9,873
-8% -$92.1K 0.01% 732
2020
Q4
$1.11M Sell
119,212
-36,540
-23% -$410K 0.01% 698
2020
Q3
$1.88M Sell
155,752
-5,383
-3% -$72.8K 0.02% 532
2020
Q2
$2.18M Buy
161,135
+494
+0.3% +$6.85K 0.02% 518
2020
Q1
$1.66M Sell
160,641
-3,214
-2% -$44K 0.02% 523
2019
Q4
$2.56M Buy
163,855
+20,076
+14% +$295K 0.03% 499
2019
Q3
$1.97M Buy
143,779
+26,234
+22% +$320K 0.02% 514
2019
Q2
$1.53M Buy
117,545
+80,199
+215% +$953K 0.02% 567
2019
Q1
$534K Buy
37,346
+1,100
+3% +$16K 0.01% 772
2018
Q4
$478K Hold
36,246
0.01% 740
2018
Q3
$398K Hold
36,246
0.01% 822
2018
Q2
$231K Sell
36,246
-9,800
-21% -$44.6K ﹤0.01% 931
2018
Q1
$166K Buy
46,046
+26,094
+131% +$111K ﹤0.01% 946
2017
Q4
$95K Sell
19,952
-200
-1% -$1.05K ﹤0.01% 953
2017
Q3
$85K Buy
20,152
+4,100
+26% +$16.1K ﹤0.01% 922
2017
Q2
$70K Buy
+16,052
New +$70.8K ﹤0.01% 902
2015
Q4
Sell
-12,887
Closed -$73K 849
2015
Q3
$73K Buy
+12,887
New +$61.8K ﹤0.01% 775
2014
Q1
Sell
-29,193
Closed -$337K 952
2013
Q4
$337K Buy
29,193
+5,557
+24% +$78.3K 0.01% 788
2013
Q3
$394K Buy
23,636
+18,236
+338% +$315K 0.01% 744
2013
Q2
$88K Buy
+5,400
New +$86.7K ﹤0.01% 939

Other funds holding LFVN

Jacobs Levy Equity Management's LFVN Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of LifeVantage (LFVN) in Q1 2026, closing a stake of 60,266 shares — an estimated $371K sold.

Jacobs Levy Equity Management first reported a position in LFVN in Q2 2013 and held it in 25 quarters. The position peaked at $2.56M in Q4 2019. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining LifeVantage position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 60,266 LifeVantage shares in Q1 2026, an estimated $371K.
  • Jacobs Levy Equity Management first reported a position in LifeVantage in Q2 2013 and held it in 25 quarters.
  • Jacobs Levy Equity Management's LifeVantage position peaked at $2.56M in Q4 2019.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.